Myoma Screw in Manipulation of Large Uterus in Total Laparoscopic Hysterectomy
Launched by KAFRELSHEIKH UNIVERSITY · May 9, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the myoma screw and comparing it to a standard tool used during a type of surgery known as total laparoscopic hysterectomy. The goal is to see which tool works better for helping doctors safely and effectively manage a larger uterus during this surgery. This trial is not yet recruiting participants, but when it starts, it will focus on women aged 30 to 60 who have a body mass index (BMI) between 25 and 40 and have been diagnosed with a large uterus due to a condition called adenomyosis.
To be eligible for the trial, participants need to have a uterus that is larger than normal, as confirmed by ultrasound tests. However, women with a BMI over 40 or those who cannot safely undergo laparoscopic surgery due to other health issues will not be included. If you participate in this trial, you can expect to receive care and monitoring as researchers gather important information about the effectiveness and safety of the myoma screw in this surgical setting. Your involvement could help improve surgical options for women facing similar health challenges in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 30-60
- • 2. BMI 25-40
- • 3. Large uterus with fundal level 12-24w diagnosed by TAS( Transabdominal Ultrasound)/TVUS(Transvaginal ultrasound)
- • 4. Adenomyosis
- Exclusion Criteria:
- • 1. BMI more than 40
- • 2. patients with contraindication for laparscopic surgery e.g cardiac and cirrhotic patients
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported